Adam Hansard - Aug 2, 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
Chief Commercial Officer
Signature
/s/ Shoshana Shendelman, as attorney-in-fact
Stock symbol
APLT
Transactions as of
Aug 2, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 08:35 PM
Previous filing
Apr 15, 2022
Next filing
Jan 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -50K -100% 0 Aug 2, 2022 Common Stock 50K $2.02 Direct F1, F2
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +50K 50K Aug 2, 2022 Common Stock 50K $1.05 Direct F1, F2
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -21.1K -100% 0 Aug 2, 2022 Common Stock 21.1K $4.17 Direct F1, F3
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +21.1K 21.1K Aug 2, 2022 Common Stock 21.1K $1.05 Direct F1, F3
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -21.1K -100% 0 Aug 2, 2022 Common Stock 21.1K $9.44 Direct F1, F4
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +21.1K 21.1K Aug 2, 2022 Common Stock 21.1K $1.05 Direct F1, F4
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -32.3K -100% 0 Aug 2, 2022 Common Stock 32.3K $23.15 Direct F1, F5
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +32.3K 32.3K Aug 2, 2022 Common Stock 32.3K $1.05 Direct F1, F5
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer -105K -100% 0 Aug 2, 2022 Common Stock 105K $34.28 Direct F1, F6
transaction APLT Employee Stock Option (Right to Buy) Disposed to Issuer +105K 105K Aug 2, 2022 Common Stock 105K $1.05 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
F2 Reflects an initial grant of 50,000 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F3 Reflects an initial grant of 21,100 Options granted on January 7, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F4 Reflects an initial grant of 21,100 Options granted on December 14, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F5 Reflects an initial grant of 81,700 Options granted on March 9, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F6 Reflects an initial grant of 179,425 Options granted on March 9, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on March 9, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.